Skip to main content

Table 2 Parents’ and medical doctors’ responses to the questionnaire on the administration of intranasal Ketamine and Midazolam (table A) and placebo (table B) via a mucosal atomiser device

From: Utility of intranasal Ketamine and Midazolam to perform gastric aspirates in children: a double-blind, placebo controlled, randomized study

A

Question

Parents (n)

Score (median)

Range

Doctors* (n)

Score (median)

Range

The use of INMK by MAD:

Helped

19

10

10-10

5/3

10

10-10

Level of child’s outlook

19

8.9

7-10

5/3

8

7-9

Level of parents’ outlook

19

9.1

8-10

5/3

9.5

9-10

Level of doctors’ outlook

-

-

 

5/3

8.5

8-10

Level of child’s tolerance of procedures

19

8.7

7-10

5/3

8.2

7-9

Would recommend to other parents

19

9.3

9-10

-

-

 

Would recommend to other doctors

-

-

 

5/3

9.4

9-10

Would like to see MAD used routinely

19

9.8

9-10

5/3

10

10

Made the procedure more acceptable

-

-

-

5/3

10

10

B

Question

Parents (n)

Score (median)

Range

Doctors* (n)

Score (median)

Range

The use of intranasal sedation (placebo) by MAD:

Helped

19

5

3-7

5/3

3

2-4

Level of child’s outlook

19

5.8

5-7

5/3

3

2-4

Level of parents’ outlook

19

4.9

3-7

5/3

5

3-7

Level of doctors’ outlook

-

-

 

5/3

4

3-5

Level of child’s tolerance of procedures

19

8.5

7-10

5/3

8

7-9

Would recommend to other parents

19

4

3-6

-

-

 

Would recommend to other doctors

-

-

 

5/3

3

1-5

Would like to see MAD used routinely

19

4

3-6

5/3

3

1-5

Made the procedure more acceptable

-

-

-

5/3

3

1-5

  1. *unbiased medical doctors involved in the painful or diagnostic procedures (text for details).
  2. INKM, intranasal midazolam and ketamine.
  3. MAD, mucosal atomiser device.